… , thus highlighting the need for novel therapeutic targets. The … , various new drugs and
treatment methods have been used to treat … , and highly dynamic environment that is composed of …

… the target of the drug, some targeted drugs are being developed, and some targeted drugs
… 诊断的肺癌患者中约80%-85%为非小细胞肺癌(non-small cell lung cancer, NSCLC), 其中肺鳞…

… ; Organ environment have a very large impact for the treatment … a novel diindolylmethane
derivative for the treatment of lung … previously treated advanced non-small cell lung cancer [J]. …

… progression; meanwhile, they could also provide therapeutic opportunities and targets. Of …
变异率，约60%的非小细胞肺癌（non-small cell lung cancer, NSCLC）中存在染色体的多倍体变异…

… 一项基于痰液样本的RASSF1A、PRDM14和3OST2联合检测研究，用于区分无瘤吸烟者和Ⅰ期
非小细胞肺癌（non-small cell lung cancer, NSCLC），结果显示敏感性达82.9%，特异性达76.4…

… Since there are no local designed and developed new drugs in Taiwan, the main goal of
this thesis is to discover and develop novel anticancer compound, MPT0E028, to become a …

… of environmental changes in body production. This paper expounds the lung cancer in amino
… progress, which provides a new way for the clinical diagnosis and new targets for cancer …

… types of cancer, including metastatic breast cancer, advanced gastric cancer, non-small cell
lung cancer (… , PMs are applied as a potential and novel alternative as drug delivery systems. …

… ment of new technologies, new targets, and new drugs in the … 非小细胞肺癌(non-small cell
lung cancer,NSCLC)血液EGFR… 000 human cancer genomes reveals the landscape of tumor …

… creating an environment favoring axonal regeneration. … provides us with a novel biomarker
and therapeutic target. How to … and stromal compartment in non-small-cell lung cancer. Br J …